IP Library Granted Patent US 11,859,022
Granted Patent B2
US 11,859,022 · App. 16/663,830 · Granted Jan 2, 2024

Alpha-1,3-glucan graft copolymers

Inventors: Rong Guan (Wilmington, DE); Michael D. Gagnon (West Grove, PA); Nikita Iltchenko (Wilmington, DE); Yefim Brun (Wilmington, DE); Laurie A. Howe (Bear, DE)
Assignee: NUTRITION & BIOSCIENCES USA 4, INC.
C08B37/0009C12N9/1048C12P19/04C12P19/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,859,022
App. No.
16/663,830
Granted
Jan 2, 2024
Kind
B2
Abstract

Compositions are disclosed herein comprising a graft copolymer that comprises: (i) a backbone comprising an alpha-1,3-glucan ether or ester compound, and (ii) one or more alpha-1,3-glucan side chains comprising at least about 50% alpha-1,3 glycosidic linkages. Further disclosed are reactions for producing such graft copolymers, as well as their use in various applications.

Claims (28)

1. A composition comprising a graft copolymer, wherein the graft copolymer comprises:

(i) a backbone consisting of an alpha-1,3-glucan ether or ester compound that has a degree of substitution (DoS) of 0.001 to 3.0, wherein the alpha-1,3-glucan ether or ester compound comprises at least 90% alpha-1,3 glycosidic linkages, and

(ii) one or more alpha-1,3-glucan side chains comprising at least 90% alpha-1,3 glycosidic linkages, wherein the one or more side chains branch from said backbone.

2. The composition of claim 1 , wherein the alpha-1,3-glucan ether or ester compound comprises at least 95% alpha-1,3 glycosidic linkages.

3. The composition of claim 2 , wherein the one or more alpha-1,3-glucan side chains comprise at least 95% alpha-1,3 glycosidic linkages.

4. The composition of claim 2 , wherein the backbone consists of the alpha-1,3-glucan ether compound.

5. The composition of claim 4 , wherein the alpha-1,3-glucan ether compound comprises an ether-linked carboxymethyl group.

6. The composition of claim 1 , wherein the weight-average degree of polymerization (DPw) of the alpha-1,3-glucan ether or ester compound is at least 15.

7. The composition of claim 1 , wherein the backbone consists of the alpha-1,3-glucan ether compound.

8. The composition of claim 7 , wherein the alpha-1,3-glucan ether compound comprises an ether-linked group that is anionic or cationic when the compound is comprised in an aqueous composition.

9. The composition of claim 7 , wherein the alpha-1,3-glucan ether compound comprises an ether-linked carboxymethyl group.

10. The composition of claim 1 , wherein the one or more alpha-1,3-glucan side chains comprise at least 95% alpha-1,3 glycosidic linkages.

11. The composition of claim 1 , wherein the composition is an aqueous composition.

12. The composition of claim 11 , wherein the aqueous composition is a dispersion of the graft copolymer.

13. The composition of claim 12 , wherein the dispersion comprises less than 1.5 w/v % of the graft copolymer.

14. The composition of claim 1 , wherein the graft copolymer is produced in a reaction composition comprising at least water, sucrose, said alpha-1,3-glucan ether or ester compound, and a glucosyltransferase enzyme that synthesizes alpha-1,3-glucan with at least 90% alpha-1,3 glycosidic linkages.

15. The composition of claim 1 , wherein the degree of polymerization (DP) or weight-average degree of polymerization (DPw) of said one or more alpha-1,3-glucan side chains is at least 100.

16. The composition of claim 1 , wherein the graft copolymer is aqueous insoluble.

17. The composition of claim 1 , wherein the alpha-1,3-glucan ether or ester compound comprises at least 99% alpha-1,3 glycosidic linkages.

18. The composition of claim 1 , wherein the graft copolymer comprises 1 to 60 mole percent of the backbone.

19. A method of producing a graft copolymer, said method comprising:

(a) contacting, in a reaction composition, at least (i) water, (ii) sucrose, (iii) an alpha-1,3-glucan ether or ester compound that has a degree of substitution (DoS) of 0.001 to 3.0, and (iv) a glucosyltransferase enzyme that synthesizes alpha-1,3-glucan comprising at least 90% alpha-1,3 glycosidic linkages,

whereby a graft copolymer according to the composition of claim 1 is produced; and

(b) optionally, isolating the graft copolymer produced in step (a).

20. A method of providing an aqueous composition, said method comprising:

(a) providing a graft copolymer according to the composition of claim 1 , and

(b) dispersing or dissolving the graft copolymer into an aqueous liquid, thereby producing the aqueous composition.

21. The method of claim 20 , wherein the graft copolymer provided in step (a) is insoluble in aqueous conditions, and wherein the graft copolymer is dispersed into the aqueous liquid in step (b).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2020
From: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
To: NUTRITION & BIOSCIENCES USA 4, INC.
Reel/Frame 055028/0496 →
Continuity (2)
Provisional Application 62750520 · Oct 25, 2018
Related Publication 20200131281A1 · Apr 30, 2020